HopeStage
Back to all studies
CompletedNCT04578756

Long-term cariprazine safety in young people with schizophrenia, bipolarity, or autism

About this title

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Read the official source — NCT04578756
Medication studyAges 5–17United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 5 years to 17 years.

Listed locations
Dothan and 41 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 1, 2021
Recruitment status
Completed
Enrollment listed in the registry
310
Sponsor
AbbVie
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 5 Years to 17 Years
Official registry ID
NCT04578756
Official title
Show the full official title

A 52-Week, Multicenter, Open-Label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Subjects With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Dothan, United States · Bentonville, United States · Anaheim, United States

33 more locations
  • Long Beach, United States
  • Orange, United States
  • Rancho Cucamonga, United States
  • San Diego, United States
  • Upland, United States
  • Doral, United States
  • Gainesville, United States
  • Hialeah, United States
  • Homestead, United States
  • Lake Mary, United States
  • Miami, United States
  • Miami Springs, United States
  • Orlando, United States
  • Tamarac, United States
  • Atlanta, United States
  • Decatur, United States
  • Dunwoody, United States
  • Hoffman Estates, United States
  • Irvington, United States
  • Buffalo, United States
  • Kinston, United States
  • Avon Lake, United States
  • Cincinnati, United States
  • West Chester, United States
  • Oklahoma City, United States
  • Austin, United States
  • Dallas, United States
  • Houston, United States
  • Plano, United States
  • The Woodlands, United States
  • Everett, United States
  • Caguas, Puerto Rico
  • San Juan, Puerto Rico

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AbbVie.

Did this study involve medication?

Yes. The study involved medication, including Cariprazine Flexible Dose.

Who was this study for?

Listed age limits: 5 years to 17 years.

Want to explore more studies?

Explore studies